Alte Biosciences is a virtual pharmaceutical company focused on the discovery and development of new, more cost-effective treatments for patients with debilitating chronic diseases. Since its inception in 2003, Alte has built a proprietary portfolio of innovative drug candidates for the treatment of late onset depression, inflammatory bowel disease and rheumatoid arthritis based on new compositions of matter and drug repurposing. The Company has also created novel solutions to support the formulation and manufacture of drugs products.
The company is an affiliate of PharmaDirections, Inc., a leading drug development management company with an established track record of success in pharmaceutical value creation through risk-leveraged preclinical development and accelerated clinical proof of concept.